HC Surgical Specialists Limited (SGX:1B1)

Market Cap	56.75M
Revenue (ttm)	19.14M
Net Income (ttm)	9.03M
Shares Out	153.38M
EPS (ttm)	0.06
PE Ratio	6.29
Forward PE	n/a
Dividend	0.02 (5.62%)
Ex-Dividend Date	Mar 2, 2026

Volume	88,000
Average Volume	31,545
Open	0.3700
Previous Close	0.3750
Day's Range	0.3700 - 0.3700
52-Week Range	0.2700 - 0.3750
Beta	-0.16
RSI	56.52
Earnings Date	Jan 10, 2026

About HC Surgical Specialists

HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other g...

• Industry: Offices and Clinics of Doctors of Medicine
• Founded: 2015
• Country: Singapore
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 1B1

Financial Performance

In 2025, HC Surgical Specialists's revenue was 19.30 million, an increase of 1.77% compared to the previous year's 18.97 million. Earnings were 8.44 million, an increase of 119.42%.